- Home
- CWST vs LEGN Comparison
CWST vs LEGN Comparison
Compare CWST & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CWST
- LEGN
- Stock Information
- Founded
- CWST 1975
- LEGN 2014
- Country
- CWST United States
- LEGN United States
- Employees
- CWST N/A
- LEGN N/A
- Industry
- CWST Environmental Services
- LEGN Biotechnology: Pharmaceutical Preparations
- Sector
- CWST Utilities
- LEGN Health Care
- Exchange
- CWST Nasdaq
- LEGN Nasdaq
- Market Cap
- CWST 7.5B
- LEGN 7.0B
- IPO Year
- CWST 1997
- LEGN 2020
- Fundamental
- Price
- CWST $115.65
- LEGN $28.91
- Analyst Decision
- CWST Strong Buy
- LEGN Strong Buy
- Analyst Count
- CWST 7
- LEGN 13
- Target Price
- CWST $122.67
- LEGN $75.67
- AVG Volume (30 Days)
- CWST 493.3K
- LEGN 1.7M
- Earning Date
- CWST 05-01-2025
- LEGN 05-13-2025
- Dividend Yield
- CWST N/A
- LEGN N/A
- EPS Growth
- CWST N/A
- LEGN N/A
- EPS
- CWST 0.21
- LEGN N/A
- Revenue
- CWST $1,633,376,000.00
- LEGN $728,303,000.00
- Revenue This Year
- CWST $18.28
- LEGN $64.21
- Revenue Next Year
- CWST $7.00
- LEGN $53.69
- P/E Ratio
- CWST $571.88
- LEGN N/A
- Revenue Growth
- CWST 21.63
- LEGN 112.46
- 52 Week Low
- CWST $91.01
- LEGN $27.34
- 52 Week High
- CWST $121.24
- LEGN $60.87
- Technical
- Relative Strength Index (RSI)
- CWST 51.57
- LEGN 39.95
- Support Level
- CWST $113.16
- LEGN $28.14
- Resistance Level
- CWST $116.74
- LEGN $31.12
- Average True Range (ATR)
- CWST 2.90
- LEGN 1.87
- MACD
- CWST -0.20
- LEGN -0.16
- Stochastic Oscillator
- CWST 53.88
- LEGN 25.95
About CWST Casella Waste Systems Inc.
Casella Waste Systems Inc is a solid waste removal company, providing resource management services to residential, commercial, municipal, and industrial customers. The company's reportable segments on Geographical basis include Eastern, Western and Mid-Atlantic regions through the Resource solution segment. It generates maximum revenue from the Western region segment. The company's services include Recycling, Collection, Organics, Energy, Landfills, Special Waste as well as Professional Services.
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.